The risks of facial filler: the honest list

The risks of facial filler tend to be handled in one of two bad ways. Commercial material says it is "safe and risk-free". Alarmist material treats every complication as imminent.

Neither helps anyone decide. This is the list organised by frequency, with what is known about each item.

Very common — essentially expected

The list

Swelling. Happens to almost everyone, with intensity varying by area. Peaks at 24 to 48 hours, resolves within days.

Tenderness to the touch. A few days.

Bruising. Frequent, and more so in anyone taking anticoagulants, antiplatelet drugs or supplements that affect clotting.

Transient asymmetry. While one side goes down before the other.

None of these is a complication. They are expected reactions, and the guidance is to wait.

Common — they resolve, but they are a nuisance

Palpable irregularity. Small lumps in the first few weeks, especially in areas of thin skin. Most resolve on their own.

A result short of expectations. Insufficient quantity or misaligned expectations. Adjustable at the follow-up.

Prolonged swelling, particularly in the under-eye area, where it can last weeks.

Uncommon filler risks — these need management

Persistent nodule. Product that has clumped or been placed in the wrong plane. Treatable with hyaluronidase when it is hyaluronic acid.

Tyndall effect. A bluish cast from product placed too superficially, typical of the under-eye area. Correctable.

Migration. Product shifting beyond where it should be, most frequent in the lip.

Persistent asymmetry, from uneven distribution or from asymmetric anatomy not accounted for in the planning.

Infection. Uncommon with adequate aseptic technique. Requires treatment.

Rare — but serious

The four that matter

Here is the part that justifies all the care in choosing who treats you.

Vascular occlusion. The filler blocks or compresses a vessel, compromising blood supply to the area. It can lead to skin necrosis if not treated quickly.

Visual compromise. The most serious complication. It occurs when product reaches the circulation of the orbit, above all in treatments to the glabella, the nose and the perinasal area. It can be irreversible.

Delayed inflammatory nodule. Appears months or years later, with inflammatory signs. More associated with non-resorbable products.

Hypersensitivity reaction. Rare with hyaluronic acid, more often linked to other components of the formulation.

What the likelihood means in practice

"Rare" is not "impossible", and that is exactly why preparation matters more than the statistic.

The useful question is not "what are the odds of this happening to me". It is "if it happens, is this clinic prepared?"

That comes down to three concrete things:

• Hyaluronidase on site, not something to be ordered in
• Anatomical knowledge on the part of whoever treats you, especially of the high-risk areas
• Reachable contact outside business hours

A vascular complication treated within the first hours usually has a good outcome. The same complication treated two days later does not.

What actually reduces the risks of filler

In order of impact:

1. Who treats you — credentials, anatomical knowledge and experience in the specific area

2. Choosing a product suited to the area and the plan

3. Technique — correct plane, cannula where it is indicated, slow injection at low pressure

4. A clinical setting equipped for an adverse event

5. A complete history, including previous products

6. A product with active registration and verifiable provenance

Note what is not on the list: the brand of the product. It matters far less than the marketing suggests.

The highest-risk areas

They are not all equal, and it is worth knowing:

• Glabella — the highest risk of visual compromise
• Nose and perinasal area — high vascular risk
• Tear trough — proximity to the orbital circulation
• Nasolabial fold — the path of the facial artery

This does not mean these areas should not be treated. It means that, in them, the choice of who treats you weighs even more heavily.

When we advise against it

• In a setting without hyaluronidase on hand.
• Over unidentified previous product, before investigating.
• Permanent filler in the face, barring a very specific indication.
• In anyone travelling within the next 48 hours to somewhere without access to care.
• Without written guidance on warning signs and contact.
• In high vascular risk areas when the indication is not strong enough to justify it.

Frequently asked questions

Is facial filler safe?

It has a well-established safety profile when properly indicated and properly performed. The serious risks are rare, and the clinic's preparedness matters more than the statistic.

What is the most serious risk?

Visual compromise from occlusion of the orbital circulation. It is rare, and concentrated in specific areas.

Can a complication be reversed?

With hyaluronic acid, hyaluronidase resolves a good share of cases — provided it is used early. With non-resorbable products, management is far harder.

How long after treatment can a complication appear?

Vascular ones appear within hours. Nodules can appear within weeks or months. Delayed inflammatory nodules, even years later.

How do I reduce my risk?

By choosing carefully who treats you, disclosing everything in the medical history, checking the product, and confirming that the clinic has hyaluronidase and an emergency contact.